Smartlab Europe

Striped Nanoparticles Improve Drug Delivery System

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.
- Advertisement -

Researchers at the Massachusetts Institute of Technology (MIT) have created the first fully synthetic nanoparticles that can penetrate a cell membrane without rupturing the protective membrane and thereby killing it.

Francesco Stellacci, associate Professor in the Department of Materials Science and Engineering and Darrell Irvine, the Eugene Bell Career Development Associate Professor of Tissue Engineering are the co-leaders in this field of work. The team found out that gold nanoparticles, when coated with alternating bands of two different kinds of molecule, are able to penetrate into the cells without causing harm, while those randomly coated with the same materials are not.

This discovery could work as a breakthrough in delivering oncology drugs to the targeted tumour cells. Scientists around the world have been working at delivering potent oncology drugs and other medicines to specific cells inside the body with the help of nanoscale drug delivery systems. However, till date they have been hindered in achieving the outcome. The cells, on recognising any foreign object, tend to wrap themselves around it and encase it into a small bubble to be excreted later. Hence it keeps the drug molecule from reaching the main fluid section or cystosol of the cell where it can have the optimum effect. Therefore the gold nanoparticles, with their unique feature may be helpful in changing this drug delivery phenomenon for the better.

Moreover, scientists till date have not been able to understand how biologically derived cell-penetrating materials work. Hence, as pointed out by Darrell Irvine, the striped nanoparticles may assist scientists in learning about how their biological counterparts, like peptides penetrate living cells.

Latest stories

Related stories

Lilly Launches New AI Supercomputer for Drug Development

Eli Lilly has launched what it describes as the...

Advanced Analytical Technologies in Pharma Impurity Testing

Advanced analytical technologies in pharma impurity testing are transforming how trace contaminants are detected, identified, and controlled across the drug lifecycle. With high-resolution instrumentation, automation, and AI-driven insights, the industry is strengthening precision, data integrity, and patient safety to meet increasingly stringent purity standards.

Advancing Quality 4.0 Through Centralized Drug Knowledge 

Implementation of a unified data framework serves as the catalyst for modernizing pharmaceutical production, bridging the gap between legacy processes and intelligent automation. By consolidating disparate data streams into a cohesive repository, organizations achieve unprecedented visibility into critical quality attributes and process parameters. This transformation facilitates proactive risk mitigation and ensures that Good Manufacturing Practices are maintained through high-fidelity insights rather than retrospective analysis, ultimately fostering a culture of continuous improvement and operational excellence.

Quality Risk Management and the Role of Verified Drug Information

Effective quality risk management in pharmaceutical manufacturing hinges on the availability of verified drug information to ensure GMP compliance and product safety.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »